None of these are dose recommendations
[4] BPC-157 also interacts with the dopaminergic and serotonergic systems in the central nervous system, modulates the hypothalamic-pituitary-adrenal axis, and has documented effects on growth hormone receptor expression
The nasal spray supply format of TB-500 is of specific interest in systemic wound healing research models where repeated injectable use creates confounding tissue effects at injection sites
None is a recommendation for human administration, and neither compound should be understood as available or approved for therapeutic use
Research Quality Standards for Copper Peptide Protocols Accurate GHK-Cu administration research depends on compound purity and copper-complex integrity
Oral semaglutide 2550 mg produces the largest average reduction, followed by orforglipron closely behind ( Nausea and vomiting increase with higher semaglutide exposure, with the 50 mg oral dose showing the greatest frequency, especially during dose escalation